XML 115 R62.htm IDEA: XBRL DOCUMENT

BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Tables)

9 Months Ended

12 Months Ended

Sep. 30, 2024

Dec. 31, 2023

BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES

SCHEDULE OF NET LOSS PER SHARE

The following table summarizes the Company’s net loss per share (in thousands, except share and per share amounts):


		Three Months Ended September 30,						Nine Months Ended September 30,
		2024			2023			2024			2023
Numerator:
Net loss		$	(16,237)		$	(19,563)		$	(64,198)		$	(55,108)
Net loss attributable to common stockholders		$	(16,237)		$	(19,563)		$	(64,198)		$	(55,108)

Denominator:
Weighted-average common stock outstanding, basic and diluted			28,863,327			27,640,542			28,572,338			25,872,118
Net loss per share, basic and diluted		$	(0.56)		$	(0.71)		$	(2.25)		$	(2.13)

The following table summarizes the Company’s net loss per share:


		Year Ended December 31,
		2023			2022
Numerator:
Net loss		$	(75,521)		$	(51,511)
Net loss available to common stockholders		$	(75,521)		$	(51,511)

Denominator:
Weighted-average common stock outstanding, basic and diluted			26,331,630			24,472,104
Net loss per share, basic and diluted		$	(2.87)		$	(2.10)

SCHEDULE OF POTENTIALLY DILUTIVE SECURITIES NOT INCLUDED IN THE CALCULATION OF DILUTED NET LOSS PER SHARE

Potentially dilutive securities not included in the calculation of diluted net loss per share attributable to common stockholders because to do so would have had an anti-dilutive effect are as follows (in common stock equivalent shares):


		As of September 30,
		2024		2023
Options to purchase common stock		3,714,104		5,236,832
Unvested restricted stock units		—		25,754
		3,714,104		5,262,586

Potentially dilutive securities not included in the calculation of diluted net loss per share attributable to common stockholders because to do so would have had an anti-dilutive effect are as follows (in common stock equivalent shares):


		As of December 31,
		2023		2022
Options to purchase common stock		5,230,344		4,110,219
Unvested restricted stock units		21,968		28,881
		5,252,312		4,139,100